SMS Pharmaceuticals Limited (NSE:SMSPHARMA)

Market Cap	45.23B +65.3%
Revenue (ttm)	8.98B +10.2%
Net Income	1.02B +40.0%
EPS	11.04 +29.5%
Shares Out	93.65M
PE Ratio	43.73
Forward PE	n/a
Dividend	0.40 (0.08%)
Ex-Dividend Date	Sep 22, 2026

Volume	801,261
Open	485.80
Previous Close	483.35
Day's Range	477.30 - 491.90
52-Week Range	242.25 - 494.45
Beta	0.33
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About SMS Pharmaceuticals

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, In...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1987
• Employees: 1,617
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SMSPHARMA

Financial Performance

In fiscal year 2026, SMS Pharmaceuticals's revenue was 8.89 billion, an increase of 13.53% compared to the previous year's 7.83 billion. Earnings were 1.02 billion, an increase of 47.52%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 23, 2026

Data Sources Report a data error